We are live on ! Find out more
USPH icon

US Physical Therapy

196 hedge funds and large institutions have $998M invested in US Physical Therapy in 2022 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 67 increasing their positions, 73 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,232% more call options, than puts

Call options by funds: $9.91M | Put options by funds: $425K

0.59% more ownership

Funds ownership: 100.4%100.99% (+0.59%)

8% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 73

5% less funds holding

Funds holding: 206196 (-10)

21% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 39

30% less capital invested

Capital invested by funds: $1.42B → $998M (-$425M)

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
196
Holders Change
-10
Holders Change %
-4.85%
% of All Funds
3.38%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
31
Increased
67
Reduced
73
Closed
39
Calls
$9.91M
Puts
$425K
Net Calls
+$9.49M
Net Calls Change
+$9.86M
Name Holding Trade Value Shares
Change
Change in
Stake
PCM
26
Peregrine Capital Management
Minnesota
$6.63M -$465K -4,840 -5%
JP Morgan Chase
27
JP Morgan Chase
New York
$6.61M -$231K -2,399 -3%
Envestnet Asset Management
28
Envestnet Asset Management
Illinois
$6.44M -$471K -4,893 -5%
Principal Financial Group
29
Principal Financial Group
Iowa
$6.38M -$623K -6,480 -7%
EAM
30
EULAV Asset Management
Florida
$5.91M
APC
31
Alpine Peaks Capital
New York
$5.57M +$3.05M +31,673 +76%
Victory Capital Management
32
Victory Capital Management
Texas
$5.56M +$5.24M +54,495 +292%
Invesco
33
Invesco
Georgia
$5.34M +$293K +3,050 +5%
SI
34
Scout Investments
Missouri
$5.32M -$892K -9,276 -12%
RC
35
RBF Capital
California
$5.32M
CGH
36
Crossmark Global Holdings
Texas
$5.25M +$6.64M +69,081 New
BG
37
Bahl & Gaynor
Ohio
$4.28M -$1.79M -18,631 -25%
BA
38
Bard Associates
Illinois
$4.04M -$21.6K -225 -0.4%
GKIM
39
GW&K Investment Management
Massachusetts
$3.9M -$60.8K -632 -1%
Renaissance Technologies
40
Renaissance Technologies
New York
$3.75M +$644K +6,700 +16%
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$3.56M -$73.9K -769 -2%
RA
42
Royce & Associates
New York
$3.41M -$19.7K -205 -0.5%
Stifel Financial
43
Stifel Financial
Missouri
$3.34M +$1.64M +17,049 +64%
GLA
44
Great Lakes Advisors
Illinois
$3.05M -$159K -1,655 -4%
N
45
Nuveen
North Carolina
$2.9M -$1.92K -20 -0.1%
SEI Investments
46
SEI Investments
Pennsylvania
$2.87M +$899K +9,350 +33%
Allspring Global Investments
47
Allspring Global Investments
North Carolina
$2.81M -$1.4M -14,545 -28%
WSFS
48
Wilmington Savings Fund Society
Delaware
$2.44M +$11.3K +117 +0.4%
Daiwa Securities Group
49
Daiwa Securities Group
Japan
$2.44M -$309K -3,218 -9%
Legal & General Group
50
Legal & General Group
United Kingdom
$2.43M +$3.65K +38 +0.1%

USPH Hedge Fund Activity: Q3 2022 in Review

196 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in US Physical Therapy (USPH) for Q3 2022, worth a combined $998M — down 30% from $1.42B a quarter earlier.

Sellers outnumbered buyers: 39 funds closed out of USPH and 31 opened new positions — a net loss of 8 holders — while 73 trimmed existing stakes and 67 added.

The largest buyer was Southernsun Asset Management, opening a new position worth an estimated $17M. The largest seller was T. Rowe Price Associates, cutting an estimated $94.2M.

  • 196 institutional investors held US Physical Therapy (USPH) as of Q3 2022, down from 206 in Q2 2022.
  • Funds reported $998M of US Physical Therapy stock for Q3 2022, down 30% quarter-over-quarter.
  • 31 funds opened new US Physical Therapy positions in Q3 2022 and 39 closed out, a net change of -8 holders.
  • The largest US Physical Therapy buyer in Q3 2022 was Southernsun Asset Management, an estimated $17M added.
  • The largest US Physical Therapy seller in Q3 2022 was T. Rowe Price Associates, an estimated $94.2M sold.

Based on aggregated 13F filings for Q3 2022.